Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications.
about
Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve.MRI in multiple sclerosis: what's inside the toolbox?Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f.Management of acute exacerbations in multiple sclerosis.Is the magnetization transfer ratio a marker for myelin in multiple sclerosis?MRI correlates of disability progression in patients with CIS over 48 months.Correlating Function and Imaging Measures of the Medial Longitudinal Fasciculus.Quantification of multiple-sclerosis-related brain atrophy in two heterogeneous MRI datasets using mixed-effects modelingTreatment of multiple sclerosis in children and adolescents.Monophasic demyelination reduces brain growth in children.Reliability of longitudinal brain volume loss measurements between 2 sites in patients with multiple sclerosis: comparison of 7 quantification techniques.Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome.Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.Development and aging of superficial white matter myelin from young adulthood to old age: Mapping by vertex-based surface statistics (VBSS).Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics.
P2860
Q31027249-451E9CD9-C711-4110-AF72-A5A85E15A5E1Q31117157-EF30B3BF-379F-4FC6-848B-938F3E9D79D9Q31132442-D9FD2100-7DB0-42C1-ADE5-4110F1B2CB91Q33381171-39059361-43CF-43F7-9B45-41869AFB7670Q33670934-D77FBEFE-9473-4412-93AD-564EC9441AB1Q33896230-9257712C-6CD9-4EF9-9095-C5F68CE959B0Q34431806-0EA0A183-AF46-4D30-AE90-8631776CAA53Q35901831-BF06B64B-D96E-43CD-BEFA-0EBC1F51315DQ37217111-18EE9C7F-20BE-4885-824A-2059652BC42AQ37693918-D1C5A9E5-39FE-4C08-8FB2-34C812D19058Q38851610-B73FEAA9-36BD-4E40-A946-97D663949C44Q39586943-153E7841-FBAB-4769-AA49-51AF4440490AQ48108313-3AA321A1-C87B-4462-8B32-BAA386A2AF17Q48186695-03E59D54-0596-4359-9DC5-8F44B92E8293Q48852051-26EF2540-035C-4608-9DF3-9128CB699A58Q48865505-458FA157-0665-4C4B-911F-1B534AF8CBF8
P2860
Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Brain atrophy and magnetizatio ...... es and long-term implications.
@ast
Brain atrophy and magnetizatio ...... es and long-term implications.
@en
type
label
Brain atrophy and magnetizatio ...... es and long-term implications.
@ast
Brain atrophy and magnetizatio ...... es and long-term implications.
@en
prefLabel
Brain atrophy and magnetizatio ...... es and long-term implications.
@ast
Brain atrophy and magnetizatio ...... es and long-term implications.
@en
P2093
P2860
P1476
Brain atrophy and magnetizatio ...... es and long-term implications.
@en
P2093
Elizabeth Fisher
Jar-Chi Lee
Jean Tkach
Jeffrey A Cohen
Richard A Rudick
Robert J Fox
P2860
P304
P356
10.1191/1352458505MS1142OA
P577
2005-04-01T00:00:00Z